Find out the latest from our research teams
Our researchers are constantly working to improve patient care and develop better treatments.
New technology developed by researchers at Evelina London and King’s College London allows surgeons to immerse themselves into a patient’s heart to plan surgery using virtual reality.
NHS England have secured the first deal of its kind in Europe for a pioneering treatment for peanut allergy.
Evelina London has played an important role over the last year in caring for a small number of children and young people with paediatric multisystem inflammatory syndrome.
A study from Evelina London has suggested a new area of research to prevent coeliac disease.
A boy severely allergic to peanuts can now safely tolerate seven of them thanks to a ground-breaking trial.
A primary school boy is realising his dream of becoming a bee keeper following his participation in an international drug trial at our hospital.
A detailed analysis of children with a rare childhood syndrome linked to COVID-19 has shown that early treatment is a key factor in outcomes. The clinicians leading the study advise parents to seek medical care for their child if they are worried.
New research has found that children who were allergic to one type of nut could safely eat, on average, nine other types of nuts.
The TV presenter and children’s author and illustrator visited Evelina London to talk about her new book and encourage children to study science.
A two-year-old girl has become the youngest child in the world to undergo deep brain stimulation.
Evelina London’s neuromuscular service has received funding of £193,487 from the charity Duchenne UK.
Results of a trial, which took place at Evelina London, have been published in the New England Journal of Medicine.
Scientists from Evelina London and King’s College London have developed a new method using MRI to produce detailed 3D images of the fetal heart.
More than 70 babies from our neonatal unit took part in a ground-breaking trial which looked at giving platelet transfusions, the cells that help the blood to clot, to babies born before 34 weeks.
Researchers from Evelina London Children’s Hospital and King’s College London have taken part in a major study that could lead to a ground-breaking new treatment for peanut allergy.
A father is competing in an ‘urban triathlon’ to thank Evelina London after his daughter received a cutting-edge treatment to prevent brain damage.
Heart abnormalities can now be diagnosed in babies at an earlier stage of pregnancy thanks to high resolution scanners in the new fetal cardiology unit at Evelina London.